Article ID Journal Published Year Pages File Type
9956510 International Journal of Cardiology 2005 6 Pages PDF
Abstract
Rosuvastatin has the same acquisition costs as and is more efficacious than atorvastatin in lowering LDL-C and treating patients to target LDL-C levels.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Cardiology and Cardiovascular Medicine
Preview
Rosuvastatin is cost-effective compared with atorvastatin in reaching cholesterol goals
Authors
, , ,